As Novo Nordisk's CFO, Karsten Munk Knudsen, said during the earnings call: We are serving almost two-thirds of the global GLP-1 market and then competition [is] sitting on the remaining one-third.

It interacts with GLP-1 receptors in the brain to reduce food desire ... Szilvásy-Szabó A, Willenbrock H, Secher A, Knudsen LB, Hogendorf WFJ. Semaglutide lowers body weight in rodents via distributed ...

As the potential of GLP-1 agonists for addiction gains traction, big pharma is also starting to take notice, namely the two ...

NotCo announced Thursday the launch of its GLP Booster, a product that can be mixed into any food to naturally help you feel ...